CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307 | -40.6% | 26,220 | -31.8% | 0.02% | -43.9% |
| Q2 2023 | $517 | +18.3% | 38,438 | +45.7% | 0.04% | +28.1% |
| Q1 2023 | $437 | -9.0% | 26,379 | +2.2% | 0.03% | -20.0% |
| Q4 2022 | $480 | -99.9% | 25,814 | -7.2% | 0.04% | +21.2% |
| Q3 2022 | $357,000 | +138.0% | 27,825 | +30.4% | 0.03% | +135.7% |
| Q2 2022 | $150,000 | +56.2% | 21,335 | +83.7% | 0.01% | +366.7% |
| Q1 2022 | $96,000 | +68.4% | 11,614 | +7.2% | 0.00% | +50.0% |
| Q3 2021 | $57,000 | -32.1% | 10,838 | -40.2% | 0.00% | -71.4% |
| Q1 2021 | $84,000 | – | 18,138 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |